For decades, genomic research has operated under a convenient simplification: treating genetic diversity primarily as a collection of single-letter typos. Genome-wide association studies (GWAS) and evolutionary analyses have heavily prioritized Single Nucleotide Polymorphisms (SNPs) and Single Nucleotide Variants (SNVs). Point mutations are computationally clean, biallelic, and easy to track using standard sequencing arrays.
However, this single-letter focus creates a profound blind spot. By looking only at typos, we overlook instances where entire chapters of the genetic code are duplicated, deleted, inverted, or moved to completely different chromosomes. These large-scale changes are known as Structural Variations (SVs).
As Peter H. Sudmant demonstrated in An integrated map of structural variation in 2,504 human genomes, while SNPs are more numerous by count, SVs actually account for the vast majority of varying base pairs between individual genomes. Because an individual structural rearrangement can alter thousands or millions of base pairs at once, SVs exert a disproportionately massive influence on gene expression and phenotypic diversity.
The Mechanics of Outsized Effect Sizes
Why do structural variants alter phenotypes so much more drastically than point mutations? The answer lies in two primary biological mechanisms: gene dosage and regulatory rewiring.
Gene Dosage and Copy Number Variation
When a segment of DNA containing a gene is duplicated or deleted, it directly alters the "dosage" of that gene—meaning how many copies are available to be transcribed into protein.
This dosage effect drives significant phenotypic variation. For example, [Yehudit Hasin-Brumshtein] et al. mapped copy-number variations (CNVs) in human olfactory receptors in High-Resolution Copy-Number Variation Map Reflects Human Olfactory Receptor Diversity and Evolution, revealing that roughly 25% of human "smell genes" vary in copy number between individuals. This structural mosaic explains why human sensory perception varies so widely from person to person.
When dosage changes occur in critical pathways, they drive complex diseases. In neurogenomics, [Shanker Swaminathan] et al. (Analysis of Copy Number Variation in Alzheimer’s Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals) and [Li Shen] et al. (Analysis of Copy Number Variation in Alzheimer’s Disease: The NIALOAD/ NCRAD Family Study) identified large-scale deletions and duplications in genes like CHRFAM7A and IMMP2L. These structural alterations disrupt mitochondrial and neurological pathways far more severely than single-nucleotide swaps, yet they are frequently missed by standard SNP-based screening pipelines.
Rewiring the Regulatory Landscape
SVs do not need to overlap with a protein-coding gene to destroy its function. Instead, they can alter the three-dimensional control architecture of the genome by moving or deleting regulatory elements like enhancers and promoters.
Standard Genome: [ Super-Enhancer ] -------- ( Megabases of DNA ) --------> [ Target Gene ]
| (Normal Expression)
Structural Deletion: [ // Deleted // ] ---------------------------------------> [ Target Gene ]
| (Gene Silenced)
This mechanism was validated by [Marsha M. Wheeler] et al. in Whole genome sequencing identifies structural variants contributing to hematologic traits in the NHLBI TOPMed program. The authors used CRISPR genome editing to demonstrate that a specific deletion found in individuals of African ancestry physically removes a remote enhancer for the S1PR3 gene, directly causing lower monocyte counts. This structural variant acts as the primary causal driver of the trait, operating completely independently of any nearby SNPs.
Similarly, [Jinlong Shi] et al. applied long-read sequencing in Structural variants involved in high-altitude adaptation detected using single-molecule long-read sequencing to show that a large deletion disrupting a super-enhancer for the EPAS1 gene is what allows Tibetan populations to adapt to low-oxygen environments.
Even at a smaller scale, structural changes like small insertions and deletions (indels) can completely shatter transcription factor binding sites (TFBS). As modeled by [Calvin Wing Yiu Chan] et al. in Impact of cancer mutational signatures on transcription factor motifs in the human genome, ignoring these structural disruptions leaves a massive gap in our ability to predict how somatic mutations alter regulatory footprints in the non-coding genome.
The Cost of Omission: Missing Heritability and Bias
When predictive models ignore SVs, they suffer from two major flaws: they fail to capture the true genetic architecture of traits, and they introduce severe ancestral biases.
Ohad Manor demonstrated in Robust Prediction of Expression Differences among Human Individuals Using Only Genotype Information that moving from mere correlation to true prospective prediction of gene expression requires incorporating complex structural variants like insertions, deletions, and CNVs alongside standard SNPs.
Furthermore, standard GWAS pipelines often rely on imputation—using known SNP patterns to guess missing genetic data. In Genome-wide association study of red blood cell traits in Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos, [Chani J. Hodonsky] et al. showed that specialized, direct analysis of copy number variants reveals significantly larger effect sizes on physiological traits than standard SNP imputation methods can capture.
When studies fail to look directly at structural variants, they also miss ancestry-specific drivers. In a subsequent multi-ethnic study, Ancestry-specific associations identified in genome-wide combined-phenotype study of red blood cell traits emphasize benefits of diversity in genomics, [Chani J. Hodonsky] et al. uncovered 11 previously unreported structural signals at the HBA1/2 locus unique to African and Amerindian ancestries.
This omission severely limits clinical risk modeling. [Nicola Picchiotti] et al. argued in Post-Mendelian genetic model in COVID-19 that omitting complex structural variations—such as non-biallelic polymorphisms and germline CNVs—prevents an accurate calculation of an individual's total genetic liability for severe disease outcomes.
A Universal Driver Across Species
The outsized impact of structural variation is not unique to human biology; it is a foundational mechanism across all domains of life, driving agricultural traits, bacterial evolution, and cancer progression.
Agricultural Breeding and Super-Pangenomes
In plant genomics, relying on a single reference genome misses the vast structural diversity within a species. [Silong Sun] et al. discovered in Extensive intraspecific gene order and gene structural variations between Mo17 and other maize genomes that over 20% of genes between two standard maize lines exhibit major structural variations or large-effect mutations rather than simple point mutations. These massive structural differences are the primary engine behind "hybrid vigor" in agriculture.
Similarly, [Jian Guo] et al. constructed a structural map in An integrated peach genome structural variation map uncovers genes associated with fruit traits, proving that large-scale deletions and inversions act as the primary genetic switches controlling fruit shape, color, and ripening speed.
This reality has forced a shift toward "super-pangenomes." As reviewed by [Xiaoqin Huang] et al. in Current status and prospects of super-pangenome studies in plants, modern breeding programs must prioritize tracking and manipulating large-scale structural changes over simple sequence polymorphisms to successfully introduce traits like climate resilience and high yield from wild relatives into domestic crops.
Cellular and Microbial Evolution
Even in rapidly multiplying populations, structural rearrangements dictate macro-level behavior. [Sheyda Azimi] et al. demonstrated in Allelic polymorphism shapes community function in evolving Pseudomonas aeruginosa populations that large-scale genomic rearrangements within bacterial communities drive the loss of social traits, which unexpectedly triggers antibiotic resistance without any direct drug exposure.
Finally, in somatic evolution and cancer progression, tracking point mutations alone obscures the true evolutionary history of a lineage. [Narges Rezaie] et al. (Somatic point mutations are enriched in non-coding RNAs with possible regulatory function in breast cancer) and [Senbai Kang] et al. (SIEVE: joint inference of single-nucleotide variants and cell phylogeny from single-cell DNA sequencing data) both emphasize that frameworks must move past the restrictive "infinite-sites" model of single-letter changes. Incorporating insertions, deletions, and structural rearrangements into phylogenetic algorithms is the only way to accurately reconstruct how tumors evolve and map the non-coding drivers of disease.
Key Foundational Work
Analysis of Copy Number Variation in Alzheimer’s Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals (2012) — contributed 1 concept elements to this direction.
High-Resolution Copy-Number Variation Map Reflects Human Olfactory Receptor Diversity and Evolution (2008) — contributed 1 concept elements to this direction.
Analysis of Copy Number Variation in Alzheimer’s Disease: The NIALOAD/ NCRAD Family Study (2012) — contributed 1 concept elements to this direction.